A new method of treatment–a slow-dissolving tablet that stays in the mouth for 12 hours–has been approved by the FDA for replacing testosterone in males with a deficiency and/or hypogonadism. Signs and symptoms of hypogonadism can include decreased sexual desire, erectile dysfunction (ED), fatigue, depression, reduced muscle mass, and osteoporosis. The product is called Striant(R) (testosterone buccal system) mucoadhesive (CIII) and is manufactured by Columbia Laboratories. Read more about the safety concerns of using Striant when other conditions are present.
The safety of HRT for women has already been called into question. But for some people the effects of HRT may be powerful enough that they will choose to overlook safety concerns.